Basics&of&Diabetes&and&Medications& Educational&Handouts&
|
|
- Constance Carter
- 6 years ago
- Views:
Transcription
1 BasicsofDiabetesandMedications ShirleyFleishman,N,CDE UniversityofVirginia DiabetesEducaDonand ManagementProgram EducationalHandouts! BasicsofDiabetesandMedicaDons(handoutofslides)! Hyperglycemia! Hypoglycemia! FootCare 1
2 ClassTopics " BasicsofDiabetesandMedicaDon " Whatdiabetesis;howitisdiagnosed " Targetbloodglucoseranges " WhybloodglucosemaPers;complicaDons " DiabetesmedicaDons:oralandinsulin " NutriDonBasics " lucosecontrol,acdvity,andstress " EatSmart,ChangeYourLifestyle HowareDiabetesandPre:diabetesDiagnosed?! Diabetes # A1c>6.5% * # FasDngbloodglucose 126mg/dl * # Twohourbloodglucose 200mg/dlduringanoralglucose tolerancetest * # andombloodglucose 200mg/dlplusclinicalsymptoms! Pre]diabetes # FasDngbloodglucose100to125mg/dl *Shouldberepeatedinabsenceofclinicalsymptoms 2
3 3 CommonTypesofDiabetes " Type1diabetes $ 5%to10%ofdiagnosedcasesofdiabetes " Type2diabetes $ 90%to95%ofdiagnosedcasesofdiabetes Normal'Func,on' No'Diabetes'
4 4 Type'2'Diabetes' nsulin'esistance' Type'1'Diabetes' or' Late'Stage'Type'2' Li=le'or'No'nsulin'
5 TargetBloodlucoseoals! Beforemeals: 80]130mg/dl! Abermeals: Lessthan180mg/dl (aimfornomorethan50mg/dlincrease frommeals) ComparisonChartofA1Candlucose A1C'%' Es,mated'Average'lucose'
6 WhyDoesBloodlucoseMatter?! Toreducetheshort]termsymptomsofhigh bloodglucosevalues.! Toreducelong]termcomplicaDons. LargeVesselComplications! Heartdisease(Cardiovasculardisease)! Stroke/TA(Cerebrovasculardisease)! PoorcirculaDontolegsandfeet(Peripheral vasculardisease) 6
7 TeststoDiscusswithYourHealthCareProvider Test' ADA'ecommended'Value' Frequency' Bloodpressure Nomorethan140/80 Ateveryvisit A1c Lessthan7% 2]4Dmesperyear Microalbuminuria (urinekidneytest) Lessthan30mg Onceperyear Cholesterol Lessthan200 Onceperyear Triglycerides Lessthan150 Onceperyear HDL LDL Men:40orhigher Women:50orhigher Lessthan100(lowrisk) Lessthan70(withCVD) Onceperyear Onceperyear SmallVesselComplications! Eyedisease! Kidneydisease # Microalbumintest! Nervedisease # Autonomicneuropathy " Stomach " ntesdnes " BladderandsexualfuncDon " Bloodpressure # Peripheralneuropathy " Footcareisimportant! 7
8 DiabetesMedications TwoformsofmedicaDonavailableforpersonswithdiabetes: " Oralpills(medicaDon) $ Usedintype2diabetes $ FivedrugclassesoforaldiabetesmedicaDons " njectablemedicadons $ nsulin requiredfortype1diabetes;maybenecessaryfor type2diabetesasdiseaseprogresses $ MimeDcs twodrugclasses;oneclasscanbeusedbypeople witheithertype1diabetesortype2diabetesoninsulinto improveglucoselevels;theotherclassisjustfortype2diabetes OralMedication: Sulfonylureas, " lyburide'(diabeta,'micronase,'lynase)' " lipizide'(lucotrol/lucotrol'xl)' " limepiride'(amaryl)' $ Howtheywork:theysDmulatethepancreastoproducemore insulin $ isk:potendalforlowbloodglucose takebeforeameal,and donotskipmeals! 8
9 OralMedication: Biguanides, " MeOormin'(lucophage)' " iomet'(lucophage)' " MeOormin'Extended'elease'(lucophage'X)' " Fortamet'(lucophage'X)' " lumetza'(lucophage'x)' $ Howtheywork:theycausethelivertoproducelessglucose $ isk:maycausedistress(nausea,diarrhea);usuallylastsfor7]10 days;startonlowdoseandadvanceslowly $ Benefit:mayhelpwithweightlossandreducedappeDte;notlikely tocauselowbloodglucose;cost]effecdve OralMedication: nsulin,sensitizers, " Pioglitazone'(Actos)' $ Howtheywork:theyhelpthebodybecomemoresensiDveto insulin;maytake4]6weekstoseeposidveeffectsonblood glucose $ isk:mayhavesomeswelling(fluidretendon)inlegsandfeet 9
10 OralMedication: DPP64,nhibitors, " Sitaglip,n'(Januvia)' " Janumet'(sitaglip,n'+'meformin)' " Saxaglip,n'(Onglyza)' " Linaglip,n'(Tradjenta)' " Aloglip,n'(Nesina)' $ Howtheywork:increasessecreDonofinsulinwhenblood glucoseiselevated,soithelpstoloweraber]mealrisesin bloodglucose $ Benefit:theydonotcauseweightgainandmayhavea posidveeffectoncholesterollevels $ isk:shouldnotusewithkidneyorliverdisease OralMedication SLT2,(sodium6dependent,glucose,transporter),nhibitors,, " Canagliflozin'(nvokana)' " Dapagliflozin'(Farxiga)' $ Howtheywork:transportsglucoseintokidneytubules;thisresults inimprovedglucoselevelsbyexcredonofglucoseinurine;itcreates adiuresis]likeeffect $ Benefit:decreaseA1clevels;mayhelpwithweightloss;lowers systolicbloodpressurelevels $ isk:ncreaseinurinaryinfecdons;increaseinbloodpotassium levels 10
11 CombiningOralMedication " ThedifferentclassesoforalmedicaDonsworkindifferentways tolowerbloodglucoselevels;somedmes,theyworkbeperin combinadontoimprovebloodglucosecontrol " ThemostcommoncombinaDonoforalmedicaDonsisa biguanideandasulfonylurea " SwitchingfromonesinglepilltoanotherisnotaseffecDveas addinganothertypeofdiabetesmedicine(oralmedicadonor insulin) njectablemedication: Mimetic,(ncretin), " Exena,de'(Bye=a) 'injecdon2xdaily;forpersonswith type2diabetes " Liraglu,de'(Victoza)['injecDon1xdaily;forpersonswith type2diabetes " Exena,de'extended'release'(Bydureon)'['injecDononce weekly;forpersonswithtype2diabetes' $ Howtheywork:slowsemptyingfromstomach; sdmulatesinsulinrelease $ Benefit:decreasesappeDte;helpsinweightloss $ isk:transientnausea 11
12 FrequentlyAskedQuestionsAboutnsulin " Willhavetobeoninsulinforeveroncestartit? " DoestakinginsulinmeanmydiabeteshasgoPen worse? " WillinsulininjecDonshurt? " sthisasignthat mafailureatdiabetesself] management? " Dohavetocarryacoolerwithmyinsulinsupplies? 12
13 Plasmansulin 2/4/16 nsulin Purpose: " Toallowglucosefromthebloodstreamtomoveintothecellsof thebody " Toprovidefuelandenergy " AdministeredbyinjecDononly $ Type%1]requiresinsulininjecDons;ideally,given4Dmesdaily beforemealsandbeddme $ Type%2 mayneedinsulinasdiseaseprogressesandthebody s insulinbecomesdeficient;diet,exercise,andoralmedicadon becomeineffecdveforbloodglucosecontrol;inidally,givenonce dailyatbeddme. NormalnsulinProfile,Simplified 75 Largeinsulinrise Biggerinsulinrise 50 Smallinsulinrise Smallinsulin rise 25 Basal nsulin Level Small' breakfast' Bigger' lunch' Small' snack' Big'' dinner' 4AM 7AM 10AM 1PM 4PM 7PM 10PM 1AM 4AM Time 13
14 Effective(nsulin(Therapy " Basal'Dose(NPH,Lantus,Levemir) $ BackgroundinsulinforbloodglucosecontrolwhennoteaDng " Bolus'or'Meal'Dose'(egular,Humalog,Novolog,Apidra) $ Tocoverglucoserisefromfood(mainlycarbohydrates) $ ivebeforeorabermeals " Correc,onDose'(egular,Humalog,Novolog,Apidra) $ Tocorrecthyperglycemiapre]meal,ifneeded $ ivebeforemeals Types(of(nsulin((Action( apid-acting - aspart (Novolog) - lispro (Humalog) - glulisine (Apidra ) nsulin Onset Peak Duration 5 minutes 1 to 2 hours 4 to 6 hours Short-acting (egular) 30 minutes 2 to 4 hours 6 to 10 hours ntermediate-acting (NPH) Long-acting - glargine (Lantus) - detemir (Levemir) 1 to 2 hours 4 to 8 hours 10 to 20 hours 1 to 2 hours 1 to 3 hours flat 8 to 10 hours 24 hours 18 to 24 hours 14
15 nsulin(njection(sites( " Abdomen(avoidarea2inchesaroundnavel) $ Preferredsite $ FastestrateofabsorpDon $ MoresubcutaneousDssue " Arms " Thighs " BuPocks nsulin(storage( " 36 O to86 O F(donotstorenearextremeheatorcold) " oomtemperatureifdiscardedaber28daysof beingopened " larginemustbediscardedaber28daysofuse (refrigeratedornot) " Levemir goodfor42daysaberopenedatroom temperature " Pre]filledsyringes(30days) 15
16 NeedleLengthsofnsulinSyringes! 4'mm''''''''''''6'mm ''''8'mm'''''''12.7'mm '' BarrelCapacityofnsulinSyringes 30 units 50 units 100 units 16
17 TypesofnsulinPens Novolograpid]acDnginsulin Humalograpid]acDnginsulin Apidrarapid]acDnginsulin Lantuslong]acDnginsulin Levemirlong]acDnginsulin NPHintermediate]acDngpen AdvantagesofnsulinPens Easy, accurate dosing Compact Fewer supplies required Less errors Smaller amount of insulin in cartridge (300 versus 1000 cc) 17
18 TreatmentofHypoglycemia! Lowbloodsugar(hypoglycemia) 70mg/dlorless! Treatment(15]15ule)! Takein15gramsofcarbohydrate:! 4glucosetablets! ½cupfruitjuice! 1cupofskimmilk! 2Tbsp.raisins! Wait15minutesandrecheckbloodglucose! fsdllbelow100mg/dl,repeat15gramscarbohydrate! Followtreatmentwithalightsnackofproteinandcarbohydrate (peanutbuperandcrackerso½sandwichonutsandfruit) HowDoYouManageYourDiabetes?! MedicaDon! NutriDon! Exercise! StressManagement 18
Adjusting Insulin Doses
Adjusting Insulin Doses Everyone with diabetes, including you, will need to adjust your insulin doses at some time. There are several reasons why a person may need an insulin adjustment. These reasons
More informationStroke Hyperglycemia Insulin Network Effort (SHINE) Trial Treatment Protocols. Askiel Bruno, MD, MS Protocol PI
Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Treatment Protocols Askiel Bruno, MD, MS Protocol PI SHINE Synopsis Acute ischemic stroke
More informationMixed Insulins Pick Me
Mixed Insulins Pick Me Alvin Goo, PharmD Clinical Associate Professor University of Washington School of Pharmacy and Department of Family Medicine Objectives Critically evaluate the evidence comparing
More informationInsulin Basic facts. Patient Education Patient Care Services. What is insulin? What types of insulin are there? Basal Insulin
Patient Education Insulin Basic facts Insulin is a protein made by the pancreas that allows your cells to use glucose for energy. There are different types of insulin: Basal long-acting insulin that controls
More informationClinicalTrials.gov Identifier: sanofi-aventis. Sponsor/company:
These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription Sponsor/company: sanofi-aventis ClinicalTrials.gov
More informationComprehensive Diabetes Treatment
Comprehensive Diabetes Treatment Joshua L. Cohen, M.D., F.A.C.P. Professor of Medicine Interim Director, Division of Endocrinology & Metabolism The George Washington University School of Medicine Diabetes
More informationManagement of Diabetes New Concepts New Devices New Medications. Richard J. Comi, MD Professor of Medicine Geisel School of Medicine at Dartmouth
Management of Diabetes New Concepts New Devices New Medications Richard J. Comi, MD Professor of Medicine Geisel School of Medicine at Dartmouth Objectives: At the end of this lecture, the learner will
More informationDiabetes Medical Management Plan
of Plan: School year: Diabetes Medical Management Plan This plan should be completed by the student s personal health care team and parents/guardian. It should be reviewed with relevant school staff and
More informationObjectives 2/13/2013. Figuring out the dose. Sub Optimal Glycemic Control: Moving to the Appropriate Treatment
Sub Optimal Glycemic Control: Moving to the Appropriate Treatment Judy Thomas, MSN, FNP-BC Holt and Walton, Rheumatology and Endocrinology Objectives Upon completion of this session you will be better
More informationType 2 Diabetes Mellitus Insulin Therapy 2012
Type 2 Diabetes Mellitus Therapy 2012 Michael T. McDermott MD Director, Endocrinology and Diabetes Practice University of Colorado Hospital Michael.mcdermott@ucdenver.edu Preparations Onset Peak Duration
More informationInsulin Prior Authorization with optional Quantity Limit Program Summary
Insulin Prior Authorization with optional Quantity Limit Program Summary 1-13,16-19, 20 FDA LABELED INDICATIONS Rapid-Acting Insulins Humalog (insulin lispro) NovoLog (insulin aspart) Apidra (insulin glulisine)
More informationPhysiology of Normoglycemia
Case 1 45 year-old male patient seen at the clinic (Medicine). Workplace stress (financial analyst); occasionally goes jogging. Two-year duration of T2DM. No previous cardiovascular events. Coexisting
More informationCase Study: Competitive exercise
Case Study: Competitive exercise 32 year-old cyclist Type 1 diabetes since age 15 Last HbA1 54 No complications and hypo aware On Humalog 8/8/8 and Levemir 15 Complains about significant hypoglycaemia
More informationClinical Cases in Diabetes Management. Joseph Cook D.O.
Clinical Cases in Diabetes Management Joseph Cook D.O. Objectives State the prevalence of Diabetes Mellitus in Ohio State the percentage of diabetic patients in the U.S. treated by Primary Care Physicians
More informationDisclosure 1/16/2017. Michael R. Brennan D.O., M.S., F.A.C.E Director Beaumont Endocrine Center Chief of Endocrine Beaumont Grosse Pointe 1/16/2017 2
Therapy For Diabetes Michigan Association of Osteopathic Family Physicians Mid-Winter Family Medicine Update Shanty Creek Resort, MI January 19-22nd 2017 Michael R. Brennan D.O., M.S., F.A.C.E Director
More informationSCHOOL HEALTH PLAN: DIABETES
BRANDON FLORENCE MCLAURIN NORTHWEST PELAHATCHIE RANKIN COUNTY SCHOOL DISTRICT GREAT TO BEST PISGAH PUCKETT RICHLAND RANKIN COUNTY SCHOOL DISTRICT SCHOOL HEALTH PLAN: DIABETES of Plan: Effective s: This
More informationDIABETES. Mary Bruskewitz APNP, MS, BC-ADM Clinical Nurse Specialist Diabetes. November 2013
DIABETES Mary Bruskewitz APNP, MS, BC-ADM Clinical Nurse Specialist Diabetes November 2013 mbruskewitz@outlook.com Objectives Part 1 Overview of Endocrine Physiology Pathophysiology of Diabetes Diabetes
More informationPoll Question 2. Special Boot Camp Workshop Beverly Dyck Thomassian, RN, MPH, BC ADM, CDE President, Diabetes Education Services.
Special Boot Camp Workshop Beverly Dyck Thomassian, RN, MPH, BC ADM, CDE President, Diabetes Education Services Poll Question 1 Mary takes 6 units lispro (Humalog) before dinner. Which BG result reflects
More informationLearning Objectives. Perioperative SWEET Success
Perioperative SWEET Success PERIOPERATIVE SWEET SUCCESS PRESENTED BY: KENDRA MARTIN, RN, BSN, CDE JENNIFER SIMPSON, RN, BC-ADM, MSN, CNS Disclosure to Participants Notice of Requirements For Successful
More informationShort-acting insulins. Biphasic insulins. Intermediate- and long-acting insulins
Recommended Insulin Products This guideline states the Gloucestershire Joint Formulary recommended, first choice insulin products. The intention is to support the choice of treatment for new patients,
More informationInitiation and Adjustment of Insulin Regimens for Type 2 Diabetes
Types of Insulin Rapid-acting insulin: lispro (Humalog), aspart (NovoRapid), glulisine (Apidra) Regular short-acting insulin: Humulin R, Novolin ge Toronto, Hypurin Regular Basal insulin: NPH (Humulin
More informationInsulin Basics. Bryan Primary Care Conference May 21, 2016 Shannon Wakeley MD Complete Endocrinology
Insulin Basics Bryan Primary Care Conference May 21, 2016 Shannon Wakeley MD Complete Endocrinology Disclosures Speakers Bureau for Sanofi, Astra Zeneca, Janssen, Boehringer-Ingelheim Objectives Discuss
More informationPremixed Insulin for Type 2 Diabetes. a gu i d e f o r a d u lt s
Premixed Insulin for Type 2 Diabetes a gu i d e f o r a d u lt s March 2009 What This Guide Covers / 2 Type 2 Diabetes / 3 Learning About Blood Sugar / 4 Learning About Insulin / 5 Comparing Medicines
More informationSociety for Ambulatory Anesthesia Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery
Society for Ambulatory Anesthesia Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery Girish P. Joshi, MB BS, MD, FFARCSI Anesthesia & Analgesia
More informationAACN PCCN Review. Endocrine
AACN PCCN Review Endocrine Presenter: Carol A. Rauen, RN, MS, CCNS, CCRN, PCCN, CEN Independent Clinical Nurse Specialist & Education Consultant rauen.carol104@gmail.com Endocrine I. INTRODUCTION Disorders
More informationMedications for Diabetes
Medications for Diabetes Sweet, but not too sweet Colette Raymond, Pharm D June 15, 2011 Learning Objectives At the end of this presentation you should be able to: Understand the prevalence and types of
More informationAntihyperglycemic Agents in Diabetes. Jamie Messenger, PharmD, CPP Department of Family Medicine East Carolina University August 18, 2014
Antihyperglycemic Agents in Diabetes Jamie Messenger, PharmD, CPP Department of Family Medicine East Carolina University August 18, 2014 Objectives Review 2014 ADA Standards of Medical Care in DM as they
More informationPediatric Diabetes Update Fran R. Cogen, MD, CDE Professor of Pediatrics Director, Diabetes Services
1.19.18 Pediatric Diabetes Update Fran R. Cogen, MD, CDE Professor of Pediatrics Director, Diabetes Services DISCLOSURES 1. No financial incentives 2. Volunteer Positions 1. National Certification Board
More informationNph insulin conversion to lantus
Nph insulin conversion to lantus Search 26-2-2003 RESPONSE FROM AVENTIS. We appreciate the opportunity to respond to Dr. Grajower s request for information regarding Lantus ( insulin glargine [rdna origin.
More informationSubjects are requested to perform self-monitoring of blood glucose (SMBG) 4 times per
APPENDIX 1 Insulin Titration Algorithm Subjects are requested to perform self-monitoring of blood glucose (SMBG) 4 times per day. All subjects will be contacted weekly to review hypoglycemia and adverse
More informationInsulin Regimens: Hitting Glycemia Targets
Insulin Regimens: Hitting Glycemia Targets Grant Kelley MD March 1 st, 2018 Faculty Disclosure: Financial relationships with commercial interests None Overview Mortality and Morbidity Insulin and Insulin
More informationConverting lantus to humalog 75 25
P ford residence southampton, ny Converting lantus to humalog 75 25 This page includes the following topics and synonyms: Insulin Dosing in Type 2 Diabetes, Insulin Dosing in Type II Diabetes. Thiazide
More information第十五章. Diabetes Mellitus
Diabetes-1/9 第十五章 Diabetes Mellitus 陳曉蓮醫師 2/9 - Diabetes 羅東博愛醫院 Management of Diabetes mellitus A. DEFINITION OF DIABETES MELLITUS Diabetes Mellitus is characterized by chronic hyperglycemia with disturbances
More informationTips and Tricks for Starting and Adjusting Insulin. MC MacSween The Moncton Hospital
Tips and Tricks for Starting and Adjusting Insulin MC MacSween The Moncton Hospital Progression of type 2 diabetes Beta cell apoptosis Natural History of Type 2 Diabetes The Burden of Treatment Failure
More informationType 1 Diabetes-Pathophysiology, Diagnosis, and Long-Term Complications. Alejandro J de la Torre Pediatric Endocrinology 10/17/2014
Type 1 Diabetes-Pathophysiology, Diagnosis, and Long-Term Complications Alejandro J de la Torre Pediatric Endocrinology 10/17/2014 Objectives Understand the pathophysiology of Type 1 diabetes. Be familiar
More information8/13/2016. Insulin Basics. Rapid-Acting Insulin Analogs. Current Insulin Products and Pens. Basal Insulin Analogs. History of Insulin Therapy
Insulin Basics Anabolic hormone involved in metabolism Following carbohydrate ingestion insulin release is stimulated Suppresses hepatic glucose production Stimulates peripheral glucose uptake Commercially-available
More informationIn-Hospital Management of Diabetes. Dr Benjamin Schiff Assistant Professor McGill University
In-Hospital Management of Diabetes Dr Benjamin Schiff Assistant Professor McGill University No conflict of interest to declare CLINICAL SCENARIO 62 y/o male with hx of DM 2, COPD, and HT is admitted with
More informationDiabetes: Everything You Want to Know. LCDR Bernadine John, RN, BSN, CDE
Diabetes: Everything You Want to Know LCDR Bernadine John, RN, BSN, CDE I have no financial affiliation to disclose as a conflict of interest regarding this presentation. DM Standards of Care The IHS Division
More informationLantus levemir conversion
Lantus levemir conversion Search Learn about starting insulin-naïve patients with type 2 diabetes on Levemir. Read Important Safety & Prescribing Info on the HCP Website. Lantus and Levemir have a variety
More informationInpatient Glycemic Management:
Disclosure to Participants Conflict of Interest (COI) and Financial Relationship Disclosures: Dr. Seley attended Advisory Board Meeting: Alliance (Boehringer-Ingelheim/Lilly) Bayer Diabetes Care Sanofi
More informationDiabetes: What You Need to Know
UW MEDICINE PATIENT EDUCATION Diabetes: What You Need to Know Discharge review before you leave the hospital We want to be sure that we explained your diabetes instructions well, so that you know how to
More informationV-Go : Simple to start, easy to use
V-Go : Simple to start, easy to use Patient Start Guide Make multiple daily insulin shots a thing of the past. Take control with V-Go. V-Go Customer Care personalized 1-on-1 support for you Call 1-866-881-1209
More informationJanuary 7, 5:00 p.m. EST
Study 3-151 Phase 2 Trial: Preliminary Results BIOD-531, a Concentrated Ultra-Rapid-Acting Prandial/Basal Insulin, Demonstrates Superior Post-Meal Glucose Control Compared to Marketed Prandial/Basal Insulins
More informationI. General Considerations
1 2 3 I. General Considerations A. Type I ( Juvenile Onset or IDDM) IDDM results from autoimmune destruction of beta cells inability to secrete insulin --> ketone formation --> DKA 4 Diabetic Ketoacidosis
More informationDrug Effectiveness Review Project Summary Report Long acting Insulins
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
More informationA GUIDE FOR YOUR HEALTH, WELLNESS AND SAFETY
A GUIDE FOR YOUR HEALTH, WELLNESS AND SAFETY AFTER HOURS CARE holidays, weekends, nights 1. IF YOU ARE HAVING AN EMERGENCY, CALL 911 IMMEDIATELY. 2. Our normal business hours are Monday through Friday,
More informationDiabetes Head to Toe May 31, 2017
Innovations in Insulin Joanne Reid RN CDE jmreid@gbhs.on.ca Danielle Benedict RPh Outline Setting the stage Insulin as pancreas replacement therapy Commonly used insulins New insulins Case Studies Dosing
More informationTherapy of Diabetes Mellitus
2016 edition by Jayne S. Reuben, PhD Department of Biomedical Sciences University of South Carolina School of Medicine Greenville Originally developed by Elliott Chideckel, MD Department of Medicine Robert
More informationPharmacy Plan Guidance
Pharmacy Plan Guidance The pharmacy plan is a tool used during the site readiness process to develop and document the site-specific procedures for study drug ordering, labeling and dispensing for the SHINE
More informationINSULIN THERAY دکتر رحیم وکیلی استاد غدد ومتابولیسم کودکان دانشگاه علوم پزشکی مشهد
INSULIN THERAY DIABETES1 IN TYPE دکتر رحیم وکیلی استاد غدد ومتابولیسم کودکان دانشگاه علوم پزشکی مشهد Goals of management Manage symptoms Prevent acute and late complications Improve quality of life Avoid
More informationDiabetes Mellitus II CPG
1 Diabetes Mellitus II CPG Candidates for Screening Integrated Complex Care Patients: Check Yearly Prediabetes: Check Yearly No Diabetes Mellitus (DM) Risk Factors: Check at Age 45, Repeat Every 3 Years
More informationCANDY Camp Application
CANDY Camp Application Please complete the following form and submit it by June 15, 2016. Please mail form to Bonnie Kruse, Diabetes Program Coordinator, HSHS St. Anthony s Memorial Hospital, 503 North
More informationModule 5. Understanding Insulin Therapy
Module 5. Understanding Insulin Therapy EDUCATIONAL OBJECTIVES Upon completion of this activity, participants will be better able to: 1. Define the basic physiologic concept of basal-bolus insulin; 2.
More informationWhat the Pill Looks Like. How it Works. Slows carbohydrate absorption. Reduces amount of sugar made by the liver. Increases release of insulin
Diabetes s Oral s - Pills These are some of the pills that are currently available in Canada to treat diabetes. Each medication has benefits and side effects you should be aware of. Your diabetes team
More informationCHALLENGING CASE PRESENTATION Steroid Induced Hyperglycemia
CHALLENGING CASE PRESENTATION Steroid Induced Hyperglycemia Javier Carrasco, MD, PhD Juan Ramón Jiménez Hospital University of Huelva, Spain Case Study: Medical and Social History A 60 years old female
More informationNewer Insulins. Boca Raton Regional Hospital 15th Annual Internal Medicine Conference
Newer Insulins Boca Raton Regional Hospital 15th Annual Internal Medicine Conference Luigi F. Meneghini, MD, MBA Professor of Internal Medicine, UT Southwestern Medical Center Executive Director, Global
More informationDiabetes in Pregnancy
Diabetes in Pregnancy Ebony Boyce Carter, MD, MPH Division of Maternal Fetal Medicine Washington University School of Medicine Disclosures I have no financial disclosures to report. Objectives Review the
More information24 Hour Support. Telephone Available 24 hours a day, 7 days a week
Contents Page What is SHAIRE? 1 What is basal-bolus regimen? 2 Why do I need a basal-bolus regimen? 3 How does basal insulin work? 3 How does rapid-acting insulin work? 4 How often should I test my Blood
More informationUnderstanding Diabetes and Insulin Delivery Systems
Page 1 This program has been supported by an educational grant from Sanofi Aventis Scott K. Stolte, Pharm.D. Associate Dean, Academic Affairs Bernard J. Dunn School of Pharmacy Shenandoah University Winchester,
More informationInitiating Injectable Therapy in Type 2 Diabetes
Initiating Injectable Therapy in Type 2 Diabetes David Doriguzzi, PA C Learning Objectives To understand current Diabetes treatment guidelines To understand how injectable medications fit into current
More informationPatient Education Pharmacy Services
Patient Education This handout details the types of insulin. It also covers how to store, mix and inject insulin. What is insulin? Insulin is made by the pancreas and acts as a key to move glucose (sugar)
More informationClinical Practice Guidelines
Clinical Practice Guidelines Diabetes Objective The purpose is to guide the appropriate diagnosis and management of Diabetes. This guideline is designed to assist the clinician by providing a framework
More informationBlood Sugar and Insulin
PATIENT & CAREGIVER EDUCATION Blood Sugar and Insulin This information explains high and low blood sugar levels and how to manage them. About Blood Sugar and Insulin Your body uses a sugar called glucose
More informationDiabetic Ketoacidosis
October 2015 Michael T. McDermott MD Director, Endocrinology and Diabetes Practice University of Colorado Hospital Case History HPI: 24 yo man with recent 8 lb. weight loss, increased thirst and frequent
More informationPHARMACISTS INTERACTIVE EDUCATION CASE STUDIES
PHARMACISTS INTERACTIVE EDUCATION CASE STUDIES Disclaimer: The information in this document is not a substitute for clinical judgment in the care of a particular patient. CADTH is not liable for any damages
More informationThe ABCs of MDI: Gaining a working knowledge of Multiple Daily Injection insulin therapy. Today s Presenter
FD Title Slide The ABCs of MDI: Gaining a working knowledge of Multiple Daily Injection insulin therapy learn.extension.org/events/3369 3 This material is based upon work supported by the National Institute
More informationImportant Stuff. Basal Bolus What Adjustments? Pt weighs 80kg
Diabetes Boot Camp Class 4 Beverly Dyck Thomassian, RN, MPH, BC ADM, CDE President, Diabetes Education Services Special Insulin and Pattern Management Diabetes Education Services 1998-2015. All rights
More informationObjectives. How Medicine Works to Control Blood Sugar Levels. What Happens When We Eat? What is diabetes? High Blood Glucose (Hyperglycemia)
How Medicine Works to Control Blood Sugar Levels Stacie Petersen, RN, CDE Objectives Define Diabetes List how medications work (ominous octet) Identify side effects of medications for diabetes What is
More informationObjectives. Recognize all available medical treatment options for diabetes. Individualize treatment and glycemic target based on patient factors
No disclosure Objectives Recognize all available medical treatment options for diabetes Individualize treatment and glycemic target based on patient factors Should be able to switch to more affordable
More informationPHARMACISTS INTERACTIVE EDUCATION CASE STUDIES
PHARMACISTS INTERACTIVE EDUCATION CASE STUDIES Disclaimer: The information in this document is not a substitute for clinical judgment in the care of a particular patient. CADTH is not liable for any damages
More informationBasal Bolus Insulin Therapy Frequently Asked Questions
1. What is Basal Bolus Insulin Therapy (BBIT)? 2. What evidence supports the use of subcutaneous Basal Bolus Insulin Therapy? 3. Does Basal Bolus Insulin Therapy apply to all patients? 4. What s wrong
More informationThe Alphabet Soup of Diabetes. Egils Bogdanovics M.D. Hungerford Diabetes Center
The Alphabet Soup of Diabetes Egils Bogdanovics M.D. Hungerford Diabetes Center Insulin: January 11, 1922 12 year old Leonard Thompson, on a starvation diet for 2 years received his first insulin injection
More informationLET S TALK INSULIN THE BASICS
LET S TALK INSULIN THE BASICS AUTHOR S DISCLOSURES Contracted for program development for Lifescan Canada Speaker for Lifescan, Lilly, BI, Consultant for Lilly, Janssen, Novo Nordisk, Lifescan Canada OBJECTIVES
More informationPreventing Heart Attacks and Strokes Every Day (PHASE) RCHC Medication Titration Algorithm
Preventing Heart Attacks and Strokes Every Day (PHASE) RCHC Medication Algorithm Updated 9/13/2017 PHASE Populations DM: type 2 ASCVD: hx heart attack/cad, CVA, TIA, AAA, Sx PAD Lifestyle Modifications
More informationLantus to levemir conversion
Lantus to levemir conversion The Borg System is 100 % Lantus to levemir conversion 16-6-2005 Ask the Expert on... Lantus Conversion. Karen Shapiro, PharmD, BCPS. Disclosures. June 16, 2005. Question. Would
More informationType I Type II Insulin Resistance
Insulin An aqueous hormonal solution made in the pancreas. Affects metabolism by allowing glucose to leave the blood and enter the body cells, preventing hyperglycemia. It is measured in units, e.g. 100
More informationSponsor / Company: Sanofi Drug substance(s): insulin glargine (HOE901) According to template: QSD VERSION N 4.0 (07-JUN-2012) Page 1
These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription. Sponsor / Company: Sanofi Drug substance(s):
More informationBackground: Brief review of epidemiology, diagnosis, classification and pathophysiology of diabetes mellistus.
Insulin Therapy in Diabetes Mellitus Part 1 Lekshmi T. Nair, MD, MHS Assistant Professor Department of Internal Medicine Division of Endocrinology, Diabetes and Metabolism The Ohio State University Wexner
More informationDiabetes Management: A diagnostic perspective
Diabetes Management: A diagnostic perspective Images: http://www.engadget.com/2009/09/23/bayer-introduces-countour-usb-glucose-meter/ http://www.medtronicdiabetes.com/treatment-and-products/minimed-530g-diabetes-system-with-enlite
More informationInpatient Diabetes Management: The Slippery Slope of Sliding Scale Insulin
Inpatient Diabetes Management: The Slippery Slope of Sliding Scale Insulin David Newman, MD University of North Dakota School of Medicine Sanford Health Big Sky Conference 2017 Dr. David Newman, Personal/Professional
More informationComplete this CE activity online at ProCE.com/InsulinPart2
Complete this CE activity online at ProCE.com/InsulinPart2 Case 1: A 67 year old male with T2DM History and Presentation John is a 67 year old retiree who has been visiting your pharmacy/clinic for over
More informationPatient Education Handouts Table of Contents 2013 General Diabetes Information Monitoring and Management
Patient Education Handouts Table of Contents 2013 We have highlighted some handouts that may be helpful for the new patient. Select the ones that are most useful to you. Avoid overwhelming the patient
More informationRole of Insulin Analogs in
Role of Insulin Analogs in Type 2 Diabetes Supported by an educational grant from Novo Nordisk Inc. This program is supported by an educational grant from Novo Nordisk Inc. It has been accredited by the
More informationNew Therapies for Diabetes Management: Hope or Headache?
New Therapies for Diabetes Management: Hope or Headache? Elizabeth Stephens, MD, FACP PMG- Endocrinology Elizabeth.Stephens@providence.org November 2018 Disclosures None 1 Objectives Discussion of 3 rd
More informationINSULIN OVERVIEW. Type Brand Name Onset Peak Duration Role in glucose management Page Rapid-Acting lispro min. 3-5 hrs min.
INSULIN OVERVIEW Type Brand Name Onset Peak Duration Role in glucose management Page Rapid-Acting lispro Humalog 15-30 min 30-90 min 3-5 hrs aspart glulisine Short-Acting Regular insulin NovoLog Apidra
More informationImplementing Hospital Policies & Protocols
Implementing Hospital Policies & Protocols Jane Jeffrie Seley DNP MPH GNP BC-ADM CDE CDTC FAADE FAAN Division of Endocrinology, Diabetes & Metabolism NewYork-Presbyterian Hospital Weill Cornell Medicine
More informationDiabetes School October 2016
Diabetes School October 2016 Name Change- Why? Shorter Has my name in it Emphasizes a major part of the practice Still see non-research patients Novo Nordisk Lilly sanofi aventis! Thank You to our LucasResearch
More informationDISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.
DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this
More informationReviewing Diabetes Guidelines. Newsletter compiled by Danny Jaek, Pharm.D. Candidate
Reviewing Diabetes Guidelines Newsletter compiled by Danny Jaek, Pharm.D. Candidate AL AS KA N AT IV E DI AB ET ES TE A M Volume 6, Issue 1 Spring 2011 Dia bet es Dis pat ch There are nearly 24 million
More informationINSULIN 101: When, How and What
INSULIN 101: When, How and What Alice YY Cheng @AliceYYCheng Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted in any form
More informationProviding Stability to an Unstable Disease
Basal Insulin Therapy Providing Stability to an Unstable Disease Thomas A. Hughes, M.D. Professor of Medicine - Retired Division of Endocrinology, Metabolism, and Diabetes University of Tennessee Health
More informationSponsor / Company: Sanofi Drug substance(s): Insulin Glargine (HOE901) Insulin Glulisine (HMR1964)
These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription. Sponsor / Company: Sanofi Drug substance(s):
More informationPharmacology Updates. Quang T Nguyen, FACP, FACE, FTOS 11/18/17
Pharmacology Updates Quang T Nguyen, FACP, FACE, FTOS 11/18/17 14 Classes of Drugs Available for the Treatment of Type 2 DM in the USA ### Class A1c Reduction Hypoglycemia Weight Change Dosing (times/day)
More informationCE on SUNDAY Miami, FL May 31, 2009
CE on SUNDAY Miami, FL May 31, 2009 Date: Sunday, May 31, 2009 Time: 1:15 PM 2:15 PM Location: Doubletree Miami Mart/Airport Hotel Title: Speaker(s): Understanding Diabetes and Insulin Delivery Systems
More informationDiabetic Emergencies DKA, HHS, Hypoglycemia. Disclosure. Learning Objectives
Diabetic Emergencies DKA, HHS, Hypoglycemia October 2018 Michael T. McDermott MD Director, Endocrinology and Diabetes Practice University of Colorado Hospital Disclosure Michael McDermott has no conflict
More informationToujeo to lantus conversion
P ford residence southampton, ny Toujeo to lantus conversion Chart of all the available insulins and their properties including onset of action, duration of action, available forms (vials and pens), peak
More informationWhat is shelf life of lantus
What is shelf life of lantus Search 6-6-2011 I've been told Lantus looses some of it's effectiveness after 30. Levemir has a 42 day shelf life after opening. 5 Reasons to Join Diabetic Connect;. Lantus
More informationAPPENDIX American Diabetes Association. Published online at
APPENDIX 1 INPATIENT MANAGEMENT OF TYPE 2 DIABETES No algorithm applies to all patients with diabetes. These guidelines apply to patients with type 2 diabetes who are not on glucocorticoids, have no
More informationDiabetes Devices Workshop Angela Aldrich, PharmD, PhC April Mott, PharmD, PhC, BCPS Presbyterian Medical Group 28 January 2018
Diabetes Devices Workshop Angela Aldrich, PharmD, PhC April Mott, PharmD, PhC, BCPS Presbyterian Medical Group 28 January 2018 Pumps & Sensors & Meters, Oh My! A Tale of Two Meters Technology for glucometers
More informationSupplemental Health Record and Authorization for Care of Child with Insulin Dependent Diabetes
477 Beaverkill Road Olivebridge, New York 12461 (845) 657-8333 Ext. 15 Fax (845) 657-8489 martin.bernstein@ashokancenter.org www.ashokancenter.org 2012-13 Supplemental Health Record and Authorization for
More information